Meeting
2020 ASCO Virtual Scientific Program
The incidence and impact of brain metastasis in patients with hereditary BRCA1/2 mutated invasive breast cancer in a prospectively followed cohort.
Authors
Haven Garber
The University of Texas MD Anderson Cancer Center, Houston, TX
Haven Garber , Michael Lehner , Akshara Singareeka Raghavendra , Angelica M. Gutierrez-Barrera , Debu Tripathy , Jennifer Keating Litton , Banu Arun , Nuhad K. Ibrahim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1096)
DOI
10.1200/JCO.2020.38.15_suppl.1096
Abstract #
1096
Poster Bd #
181
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Brain metastasis in patients with hereditary BRCA-mutated invasive breast cancer.
First Author: Haven Garber
Poster
2024 ASCO Genitourinary Cancers Symposium
SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline BRCA1/2 mutations.
First Author: Heather H. Cheng
Poster
2022 ASCO Annual Meeting
Reversion mutations in BRCA1 or BRCA2 genes: Resistant mechanism(s) in patients treated with platinum-based agents or poly (ADP-ribose) polymerase(PARP) inhibitors.
First Author: Sourat Darabi
Poster
2020 ASCO Virtual Scientific Program
Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients.
First Author: Xin Huang